rheumatoid arthritis
Conditions
Interventions
Personalized Exercise therapy: load exercise 3 times a week for 30 minutes. The strength of the exercise are personally adjusted by Borg scale.
Control
Sponsors
Osaka Metropolitan University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with rheumatoid arthritis who achieved remission or low disease activity with regular dose of molecular targeted therapies (b-DMARDs or ts-DMARDs) and initiated tapering molecular targeted therapies (dose reduction or spacing) within 3 months before the informed consent. Patients who can attend the hospital regularly. Patients who can read and understand Japanese language. Patients who provide a written informed consent for this study.
Exclusion criteria
Exclusion criteria: Patients who cannot stand or walk. Patients who are not allow to do exercise by the physician. Patients who have cognitive impairment. Patients for whom physicians judge as inappropriate to join this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Disease activity of rheumatoid arthritis 16 weeks after the intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| Maintenance rate of remission or low disease activity with tapered dose of molecular targeted therapies 16 weeks after the intervention. QOL of RA patients 16 weeks after the intervention. | — |
Countries
Japan
Contacts
Public ContactMOTOMU HASHIMOTO
Osaka Metropolitan University Department of Clinical Immunology
Outcome results
None listed